As of Oct 18
| -0.06 / -0.87%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 12.81, with a high estimate of 20.00 and a low estimate of 5.50. The median estimate represents a +88.10% increase from the last price of 6.81.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.